|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In Vivo Myocardial Protection From Ischemia/Reperfusion Injury by the Peroxisome Proliferator–Activated Receptor-γ Agonist Rosiglitazone显示文摘 | Tian-li Yue Jun Chen Weike Bao Padma K. Narayanan Antoine Bril Wen Jiang Paul G. Lysko Juan-Li Gu Rogely Boyce Dawn M. Zimmerman Timothy K. Hart Robin E. Buckingham Eliot H. Ohlstein | 2001 | Circulation: Journal of the American Heart Association2001，，21： | 2 |
| 2 | Expression of urotensin-Ⅱ in human coronary atherosclerosis显示文摘 | Hassan GS Douglas SA Ohlstein EH | 2005 | Peptide2005，26，12： | 1 |
| 3 | Recent oboervations with β - adrenoceptor blockade显示文摘 | Ruffolo RR Jr Feueratein GZ Ohlstein EH | 1998 | Am J Hyper1998，11，1： | 1 |
| 4 | Localization of urotensin-Ⅱ immunoreactivity in normal human kidneys and renal carcinoma显示文摘 | Shenouda A Douglas SA Ohlstein EH | 2002 | J Histochem Cytochem2002，50，7： | 1 |
| 5 | Localization of urotensin -Ⅱ immunoreactivity in normal human kidneys and renal carcinoma 显示文摘 | Shenouda A Douglas SA Ohlstein EH | 2002 | J Histochem Cytochem2002，50，7： | 1 |
| 6 | Comparative pharmacology of endothelium-derived relaxing factor and nitric oxide显示文摘 | SHIKANO K LONG C J OHLSTEIN E H | | 0，，3： | 1 |
| 7 | Human urotensin Ⅱ,the most potent mammalian vasoconstrictor identified to date,as a therapeutic target for the management of cardiovascular disease显示文摘 | Ohlstein EH | 2000 | Trends Cardiovasc Med2000，10，： | 1 |
| 8 | Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty显示文摘 | Wang X Louden C Ohlstein EH | 1996 | Arterioscler Thromb Vasc Biol1996，16，11： | 1 |
| 9 | The stem cell niche: theme and-variations 显示文摘 | Ohlstein B Kai T Dccetto E | 2004 | Curr Opin Cell Biol2004，16，6： | 1 |
| 10 | Matrix metalloproteinase expression after cerebral focal ischimia in rats inhibition of matrix metallopteinase-9 reduces infarct size显示文摘 | Romanic AM White RF Arketh A J Ohlstein EH Barone FC | 1998 | Stroke1998，8，29： | 1 |
| 11 | Human urotensin II,the most potent mammalian vasoconstrictor identified to date,as a therapeutic target for the management of cardiovascular disease显示文摘 | Douglas SA Ohlstein EH | 2000 | Trends Cardiovasc Med2000，10，： | 1 |
| 12 | Interferon-inducible protein-10 involves vascular smooth muscle cell migration,proliferation,and inflammatory response显示文摘 | Wang X Yue TL Ohlstein EH | 1996 | J Biol Chem1996，271，24： | 1 |
| 13 | Apoptosis:a potential target for discovering novel therapies for cardiovascular diseases 显示文摘 | Yue T L Ohlstein E H | 1999 | Curr Op Chem Biol1999，3，： | 1 |
| 14 | Application of in vivo and ex vivo magnetic resonance imaging for evaluation of tranilast on neointima formation following balloon angioplasty of the rat carotid artery显示文摘 | Ohlstein EH Romanic AM Clark LV | 2000 | Cardiovasc Res2000，47，： | 1 |
| 15 | Human urotensin-II,the most potent mammalian vasoconstrictor identified to date,as a therapeutic target for the management of cardiovascular disease显示文摘 | Douglas SA Ohlstein EH | 2000 | Trends Cardiovasc Med2000，10，6： | 1 |
| 16 | Pharmacology of eprosartan:an angiotensin Ⅱ receptor antagonist,exploring hypotheses from clinical data显示文摘 | Ohlstein E H Ruffolo R R | 1999 | Am Heart J1999，138，32： | 1 |
| 17 | Congestive heart failare and expresion of myocardial urotensin Ⅱ显示文摘 | Dou as SA Tayara L Ohlstein EH | 2002 | Lancet2002，359，： | 1 |
| 18 | Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells显示文摘 | Ohlstein EH Berhand G Schulze C | 1991 | Circulation Res1991，69，： | 1 |
| 19 | Carvedilol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial cells显示文摘 | Ohlstein EH Atleth AJ Storer B | 1998 | J Mol Cell Cardiol1998，30，： | 1 |
| 20 | Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury显示文摘 | Ohlstein EH Douglas SA Sung CP | 1993 | Proc Natl Acad Sci USA1993，90，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员